US medtech giant upgrades cell therapy business and uses Chemometec products

US medtech giant GE Healthcare aims to take over the market for cell therapy manufacturing by selling prefabricated production facilities with all instruments necessary for producing cell therapy, including Danish Chemometec's cell counters.

Michael Eising, CEO in Chemometec. Photo: Chemometec

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles